Skip to main content
. 2017 Dec 18;18(12):2745. doi: 10.3390/ijms18122745

Figure 1.

Figure 1

Hallmark of galectins in head and neck cancers. Gal-1, -3, -7, -8, and -9 in cancer progression affecting several pathways including proliferation, apoptosis, invasion, angiogenesis, and tumor-immune escape. Matrix Metalloproteinase (MMP); Interleukin (IL); Focal adhesion kinsase (FAK).